Genetically engineered retroviral vector particles capable of infecting non-dividing cells
CA 2360858 A1 · Owner: Dornburg, Ralph · Inventors: Dornburg, Ralph
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is a method of generating retroviral vector particles derived from retroviruses and capable of transducing therapeutic genes into non-dividing cells. Mutations made in the retroviral matrix protein (MA) enable infection of non-dividing cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.